PDGFRA and chronic intestinal pseudoobstruction: In conclusion, our data strongly suggest that a phenotypic switch occurs in the SMCs of paediatric CIPO patients and highlight the PDGFRA signalling pathway as a target for drug design for CIPO syndrome.